{
    "references": [
        {
            "bibentry": "Conserva, F, Gesualdo, L, Papale, M. A systems biology overview on human diabetic nephropathy: from genetic susceptibility to post-transcriptional and post-translational modifications. J Diabetes Res 2016; 2016: 7934504. PMID: 26798653",
            "process_entry": "True",
            "doi": "10.1155/2016/7934504",
            "pmid": "26798653",
            "pmcid": "PMC4698547",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Fox, CS, Matsushita, K, Woodward, M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012; 380: 1662–73. PMID: 23013602",
            "process_entry": "True",
            "doi": "10.1016/S0140-6736(12)61350-6",
            "pmid": "23013602",
            "pmcid": "PMC3771350",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Pagtalunan, ME, Miller, PL, Jumping-Eagle, S, et al. Podocyte loss and progressive glomerular injury in type ii diabetes. J Clin Invest 1997; 99: 342–8. PMID: 9006003",
            "process_entry": "True",
            "doi": "10.1172/jci119163",
            "pmid": "9006003",
            "pmcid": "PMC507802",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Weil, EJ, Lemley, KV, Mason, CC, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int 2012; 82: 1010–7. PMID: 22718189",
            "process_entry": "True",
            "doi": "10.1038/ki.2012.234",
            "pmid": "22718189",
            "pmcid": "PMC3472108",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Susztak, K, Raff, AC, Schiffer, M, Böttinger, EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55: 225 PMID: 16380497",
            "process_entry": "True",
            "doi": "10.2337/diabetes.55.01.06.db05-0894",
            "pmid": "16380497",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813–20. PMID: 11742414",
            "process_entry": "True",
            "doi": "10.1038/414813a",
            "pmid": "11742414",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Witko-Sarsat, V, Friedlander, M, Capeillere-Blandin, C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304–13. PMID: 8731095",
            "process_entry": "True",
            "doi": "10.1038/ki.1996.186",
            "pmid": "8731095",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Tang, DD, Niu, HX, Peng, FF, et al. Hypochlorite-modified albumin upregulates ICAM-1 expression via a MAPK-NF-kappab signaling cascade: protective effects of apocynin. Oxid Med Cell Longev 2016; 2016: 1852340. PMID: 26881015",
            "process_entry": "True",
            "doi": "10.1155/2016/1852340",
            "pmid": "26881015",
            "pmcid": "PMC4736979",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Small, DM, Coombes, JS, Bennett, N, et al. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) 2012; 17: 311–21. PMID: 22288610",
            "process_entry": "True",
            "doi": "10.1111/j.1440-1797.2012.01572.x",
            "pmid": "22288610",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Indo, HP, Yen, HC, Nakanishi, I, et al. A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr 2015; 56: 1–7. PMID: 25834301",
            "process_entry": "True",
            "doi": "10.3164/jcbn.14-42",
            "pmid": "25834301",
            "pmcid": "PMC4306659",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Gnudi, L, Coward, RJ, Long, DA. Diabetic nephropathy: Perspective on novel molecular mechanisms. Trends Endocrinol Metab 2016; 27: 820–30. PMID: 27470431",
            "process_entry": "True",
            "doi": "10.1016/j.tem.2016.07.002",
            "pmid": "27470431",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Kumar, A, Yerra, VG, Malik, RA. Comment on sharma. Mitochondrial hormesis and diabetic complications. Diabetes 2015; 64: 663–72. Diabetes 2015: 64: e32–3; discussion e34. PMID: 25713188",
            "process_entry": "True",
            "doi": "10.2337/db14-0874",
            "pmid": "25713188",
            "pmcid": "PMC4338592",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Myung, SK, Ju, W, Cho, B, et al. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 346: f10. PMID: 23335472",
            "process_entry": "True",
            "doi": "10.1136/bmj.f10",
            "pmid": "23335472",
            "pmcid": "PMC3548618",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Walsh, PC. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. J Urol 2005; 174: 1823–4. PMID: 16217295",
            "process_entry": "True",
            "doi": "10.1097/01.ju.0000183077.52404.ec",
            "pmid": "16217295",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Zhao, K, Zhao, GM, Wu, D, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 2004; 279: 34682–90. PMID: 15178689",
            "process_entry": "True",
            "doi": "10.1074/jbc.m402999200",
            "pmid": "15178689",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Szeto, HH. Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal 2008; 10: 601–19. PMID: 17999629",
            "process_entry": "True",
            "doi": "10.1089/ars.2007.1892",
            "pmid": "17999629",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Cai, M, Li, J, Lin, S, et al. Mitochondria-targeted antioxidant peptide ss31 protects cultured human lens epithelial cells against oxidative stress. Curr Eye Res 2015; 40: 822–9. PMID: 25310141",
            "process_entry": "True",
            "doi": "10.3109/02713683.2014.959607",
            "pmid": "25310141",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Zhao, WY, Han, S, Zhang, L, et al. Mitochondria-targeted antioxidant peptide ss31 prevents hypoxia/reoxygenation-induced apoptosis by down-regulating p66shc in renal tubular epithelial cells. Cell Physiol Biochem 2013; 32: 591–600. PMID: 24021885",
            "process_entry": "True",
            "doi": "10.1159/000354463",
            "pmid": "24021885",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Hou, Y, Li, S, Wu, M, et al. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy. Am J Physiol Renal Physiol 2016; 310: F547–59. PMID: 26719366",
            "process_entry": "True",
            "doi": "10.1152/ajprenal.00574.2014",
            "pmid": "26719366",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Zhao, H, Liu, YJ, Liu, ZR, et al. Role of mitochondrial dysfunction in renal fibrosis promoted by hypochlorite-modified albumin in a remnant kidney model and protective effects of antioxidant peptide SS-31. Eur J Pharmacol 2017; 804: 57–67. PMID: 28322835",
            "process_entry": "True",
            "doi": "10.1016/j.ejphar.2017.03.037",
            "pmid": "28322835",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Zhou, LL, Hou, FF, Wang, GB, et al. Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int 2009; 76: 1148–60. PMID: 19727064",
            "process_entry": "True",
            "doi": "10.1038/ki.2009.322",
            "pmid": "19727064",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Shi, XY, Hou, FF, Niu, HX, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 2008; 149: 1829–39. PMID: 18174276",
            "process_entry": "True",
            "doi": "10.1210/en.2007-1544",
            "pmid": "18174276",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Li, P, Nijhawan, D, Budihardjo, I, et al. Cytochrome c and DATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479–89. PMID: 9390557",
            "process_entry": "True",
            "doi": "10.1016/s0092-8674(00)80434-1",
            "pmid": "9390557",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Guo, ZJ, Niu, HX, Hou, FF, et al. Advanced oxidation protein products activate vascular endothelial cells via a rage-mediated signaling pathway. Antioxid Redox Signal 2008; 10: 1699–712. PMID: 18576917",
            "process_entry": "True",
            "doi": "10.1089/ars.2007.1999",
            "pmid": "18576917",
            "pmcid": "PMC6464001",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Taylor, EL, Armstrong, KR, Perrett, D, et al. Optimisation of an advanced oxidation protein products assay: its application to studies of oxidative stress in diabetes mellitus. Oxid Med Cell Longev 2015; 2015: 496271. PMID: 26113954",
            "process_entry": "True",
            "doi": "10.1155/2015/496271",
            "pmid": "26113954",
            "pmcid": "PMC4465816",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Piwowar, A, Knapik-Kordecka, M, Warwas, M. Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients. Br J Biomed Sci 2009; 66: 194–9. PMID: 20095128",
            "process_entry": "True",
            "doi": "10.1080/09674845.2009.11730273",
            "pmid": "20095128",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Chen, X, Zhong, Z, Xu, Z, et al. 2',7'-dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy. Free Radic Res 2010; 44: 587–604. PMID: 20370560",
            "process_entry": "True",
            "doi": "10.3109/10715761003709802",
            "pmid": "20370560",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Brosius, FC, Coward, RJ. Podocytes, signaling pathways, and vascular factors in diabetic kidney disease. Adv Chronic Kidney Dis 2014; 21: 304–10. PMID: 24780459",
            "process_entry": "True",
            "doi": "10.1053/j.ackd.2014.03.011",
            "pmid": "24780459",
            "pmcid": "PMC4075065",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Gu, J, Yang, M, Qi, N, et al. Olmesartan prevents microalbuminuria in db/db diabetic mice through inhibition of angiotensin ii/p38/sirt1-induced podocyte apoptosis. Kidney Blood Press Res 2016; 41: 848–64. PMID: 27871084",
            "process_entry": "True",
            "doi": "10.1159/000452588",
            "pmid": "27871084",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Gao, F, Yao, M, Cao, Y, et al. Valsartan ameliorates podocyte loss in diabetic mice through the notch pathway. Int J Mol Med 2016; 37: 1328–36. PMID: 26985716",
            "process_entry": "True",
            "doi": "10.3892/ijmm.2016.2525",
            "pmid": "26985716",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Lv, W, Zhang, Y, Guan, G, et al. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats. Pharmacology 2013; 92: 227–34. PMID: 24158161",
            "process_entry": "True",
            "doi": "10.1159/000354600",
            "pmid": "24158161",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Guo, H, Cao, A, Chu, S, et al. Astragaloside IV attenuates podocyte apoptosis mediated by endoplasmic reticulum stress through upregulating sarco/endoplasmic reticulum ca2+-ATPase 2 expression in diabetic nephropathy. Front Pharmacol 2016; 7: 500. PMID: 28066247",
            "process_entry": "True",
            "doi": "10.3389/fphar.2016.00500",
            "pmid": "28066247",
            "pmcid": "PMC5174081",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Langer, S, Kreutz, R, Eisenreich, A. Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions. J Nephrol 2016; 29: 765–73. PMID: 26733332",
            "process_entry": "True",
            "doi": "10.1007/s40620-015-0258-1",
            "pmid": "26733332",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Korkmaz, GG, Konukoglu, D, Kurtulus, EM, et al. Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients. Scand J Clin Lab Invest 2013; 73: 641–9. PMID: 24152132",
            "process_entry": "True",
            "doi": "10.3109/00365513.2013.846477",
            "pmid": "24152132",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "Gradinaru, D, Borsa, C, Ionescu, C, Margina, D. Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. J Proteomics 2013; 92: 313–22. PMID: 23587667",
            "process_entry": "True",
            "doi": "10.1016/j.jprot.2013.03.034",
            "pmid": "23587667",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Casalena, G, Krick, S, Daehn, I, et al. Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro. Am J Physiol Renal Physiol 2014; 306: F1372–80. PMID: 24598802",
            "process_entry": "True",
            "doi": "10.1152/ajprenal.00608.2013",
            "pmid": "24598802",
            "pmcid": "PMC4042102",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Chacko, BK, Reily, C, Srivastava, A, et al. Prevention of diabetic nephropathy in Ins2(+/) −(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochem J 2010; 432: 9–19. PMID: 20825366",
            "process_entry": "True",
            "doi": "10.1042/BJ20100308",
            "pmid": "20825366",
            "pmcid": "PMC2973231",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "Jha, JC, Banal, C, Chow, BS, et al. Diabetes and kidney disease: Role of oxidative stress. Antioxid Redox Signal 2016; 25: 657–84. PMID: 26906673",
            "process_entry": "True",
            "doi": "10.1089/ars.2016.6664",
            "pmid": "26906673",
            "pmcid": "PMC5069735",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "Ott, M, Gogvadze, V, Orrenius, S, Zhivotovsky, B. Mitochondria, oxidative stress and cell death. Apoptosis 2007; 12: 913–22. PMID: 17453160",
            "process_entry": "True",
            "doi": "10.1007/s10495-007-0756-2",
            "pmid": "17453160",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Yu, L, Liu, Y, Wu, Y, et al. Smad3/nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage. Cell Signal 2014; 26: 2979–91. PMID: 25229402",
            "process_entry": "True",
            "doi": "10.1016/j.cellsig.2014.08.030",
            "pmid": "25229402",
            "xmlid": "CIT0040"
        },
        {
            "bibentry": "Kluck, RM, Bossy-Wetzel, E, Green, DR, Newmeyer, DD. The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science 1997; 275: 1132–6. PMID: 9027315",
            "process_entry": "True",
            "doi": "10.1126/science.275.5303.1132",
            "pmid": "9027315",
            "xmlid": "CIT0041"
        },
        {
            "bibentry": "Eisenreich, A, Langer, S, Herlan, L, Kreutz, R. Regulation of podoplanin expression by microrna-29b associates with its antiapoptotic effect in angiotensin ii-induced injury of human podocytes. J Hypertens 2016; 34: 323–31. PMID: 26867059",
            "process_entry": "True",
            "doi": "10.1097/hjh.0000000000000799",
            "pmid": "26867059",
            "xmlid": "CIT0042"
        },
        {
            "bibentry": "Sanz, AB, Santamaria, B, Ruiz-Ortega, M, et al. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 2008; 19: 1634–42. PMID: 18632846",
            "process_entry": "True",
            "doi": "10.1681/asn.2007121336",
            "pmid": "18632846",
            "xmlid": "CIT0043"
        }
    ],
    "localid": "MED-30734599",
    "doi": "10.1080/14756366.2018.1488697",
    "pmid": "10.1080/14756366.2018.1488697",
    "pmcid": "30734599",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30734599/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,296)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),299,170)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,303)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Following the discovery of the association of the reduction of the podocyte number, proteinuria and glomerular filtration membrane impairment in Pima Indians with type 2 DM in 1997 by Pagtalunan et al.3, the relationship between podocyte loss and DKD was also confirmed by multiple clinical studies4. Podocytes are terminally differentiated epithelial cells that are important components of the glomerular filtration membrane. Podocyte number reduction mainly occurs through apoptosis and detachment, resulting in irreversible damage to the glomerular filtration function5. This suggests that podocytes act as a key cellular basis in the development of DKD and a new effective target in DKD therapy.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 3,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,303)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Following the discovery of the association of the reduction of the podocyte number, proteinuria and glomerular filtration membrane impairment in Pima Indians with type 2 DM in 1997 by Pagtalunan et al.3, the relationship between podocyte loss and DKD was also confirmed by multiple clinical studies4. Podocytes are terminally differentiated epithelial cells that are important components of the glomerular filtration membrane. Podocyte number reduction mainly occurs through apoptosis and detachment, resulting in irreversible damage to the glomerular filtration function5. This suggests that podocytes act as a key cellular basis in the development of DKD and a new effective target in DKD therapy.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),432,147)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,177)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 6,
                "xref_id": "CIT0007",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),180,289)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 7,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),471,149)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),1,262)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),265,122)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "CIT0011",
                "rp_string": "11",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),691,252)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0012",
                "rp_string": "12",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),691,252)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),1,326)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_xpath": "substring(string(/article/body/sec[1]/p[5]),140,11)",
                "pl_string": "s\n13\n\n,\n\n14"
            },
            {
                "n_rp": 13,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),1,326)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_xpath": "substring(string(/article/body/sec[1]/p[5]),140,11)",
                "pl_string": "s\n13\n\n,\n\n14"
            }
        ],
        [
            {
                "n_rp": 14,
                "xref_id": "CIT0015",
                "rp_string": "15",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),459,279)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 15,
                "xref_id": "CIT0016",
                "rp_string": "16",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),740,196)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "General antioxidants, such as vitamin E, β-carotene, and vitamin A, have been shown to have no obvious benefits in reducing DM complications13,14, inferring that these compounds might be distributed in the cytoplasm or extracellularly, could not enter the mitochondria, and had difficulty in exerting antioxidant effects. A new type of cell-permeable tetrapeptide was initially designed and synthesised by Szeto and Schiller and named the SS peptides. Among these peptides, SS-31 was reported to target and accumulate in the inner membrane of mitochondria and scavenge mtROS, thereby preventing mitochondrial depolarisation, mitochondrial permeability transition, and cytochrome c (cyt c) release from mitochondria to cytoplasm15. The SS peptide protects N2A neuroblastoma cells, Caco-2 colon cancer cells16, HLEB-3 human lens epithelial cells17, NRK52E rat renal tubular cells18, and mouse mesangial cells19 from death. However, the roles and mechanisms of the SS peptide in podocytes under the circumstances of DM and oxidative stress remain largely unknown.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 16,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),740,196)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "General antioxidants, such as vitamin E, β-carotene, and vitamin A, have been shown to have no obvious benefits in reducing DM complications13,14, inferring that these compounds might be distributed in the cytoplasm or extracellularly, could not enter the mitochondria, and had difficulty in exerting antioxidant effects. A new type of cell-permeable tetrapeptide was initially designed and synthesised by Szeto and Schiller and named the SS peptides. Among these peptides, SS-31 was reported to target and accumulate in the inner membrane of mitochondria and scavenge mtROS, thereby preventing mitochondrial depolarisation, mitochondrial permeability transition, and cytochrome c (cyt c) release from mitochondria to cytoplasm15. The SS peptide protects N2A neuroblastoma cells, Caco-2 colon cancer cells16, HLEB-3 human lens epithelial cells17, NRK52E rat renal tubular cells18, and mouse mesangial cells19 from death. However, the roles and mechanisms of the SS peptide in podocytes under the circumstances of DM and oxidative stress remain largely unknown.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 17,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),740,196)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "General antioxidants, such as vitamin E, β-carotene, and vitamin A, have been shown to have no obvious benefits in reducing DM complications13,14, inferring that these compounds might be distributed in the cytoplasm or extracellularly, could not enter the mitochondria, and had difficulty in exerting antioxidant effects. A new type of cell-permeable tetrapeptide was initially designed and synthesised by Szeto and Schiller and named the SS peptides. Among these peptides, SS-31 was reported to target and accumulate in the inner membrane of mitochondria and scavenge mtROS, thereby preventing mitochondrial depolarisation, mitochondrial permeability transition, and cytochrome c (cyt c) release from mitochondria to cytoplasm15. The SS peptide protects N2A neuroblastoma cells, Caco-2 colon cancer cells16, HLEB-3 human lens epithelial cells17, NRK52E rat renal tubular cells18, and mouse mesangial cells19 from death. However, the roles and mechanisms of the SS peptide in podocytes under the circumstances of DM and oxidative stress remain largely unknown.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 18,
                "xref_id": "CIT0019",
                "rp_string": "19",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),740,196)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "General antioxidants, such as vitamin E, β-carotene, and vitamin A, have been shown to have no obvious benefits in reducing DM complications13,14, inferring that these compounds might be distributed in the cytoplasm or extracellularly, could not enter the mitochondria, and had difficulty in exerting antioxidant effects. A new type of cell-permeable tetrapeptide was initially designed and synthesised by Szeto and Schiller and named the SS peptides. Among these peptides, SS-31 was reported to target and accumulate in the inner membrane of mitochondria and scavenge mtROS, thereby preventing mitochondrial depolarisation, mitochondrial permeability transition, and cytochrome c (cyt c) release from mitochondria to cytoplasm15. The SS peptide protects N2A neuroblastoma cells, Caco-2 colon cancer cells16, HLEB-3 human lens epithelial cells17, NRK52E rat renal tubular cells18, and mouse mesangial cells19 from death. However, the roles and mechanisms of the SS peptide in podocytes under the circumstances of DM and oxidative stress remain largely unknown.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            }
        ],
        [
            {
                "n_rp": 19,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[1]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[1]),1,309)",
                "containers_title": [
                    "Materials and methods",
                    "HOCl-RSA/MSA preparation and content determination"
                ]
            }
        ],
        [
            {
                "n_rp": 20,
                "xref_id": "CIT0015",
                "rp_string": "15",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[2]),1,85)",
                "containers_title": [
                    "Materials and methods",
                    "Preparation and location determination of SS-31"
                ]
            }
        ],
        [
            {
                "n_rp": 21,
                "xref_id": "CIT0021",
                "rp_string": "21",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),1,149)",
                "containers_title": [
                    "Materials and methods",
                    "Cell culture"
                ]
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[2]/sec[5]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[5]/p),158,229)",
                "containers_title": [
                    "Materials and methods",
                    "Biochemical parameters"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0021",
                "rp_string": "21",
                "rp_xpath": "/article/body/sec[2]/sec[7]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[7]/p),121,121)",
                "containers_title": [
                    "Materials and methods",
                    "Determination of podocyte number in the glomerulus with immunohistochemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[2]/sec[9]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[9]/p[1]),1,120)",
                "containers_title": [
                    "Materials and methods",
                    "Detection of oxidative stress parameters"
                ]
            }
        ],
        [
            {
                "n_rp": 25,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[2]/sec[10]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[10]/p[1]),234,114)",
                "containers_title": [
                    "Materials and methods",
                    "Immunoprecipitation and western blotting"
                ]
            }
        ],
        [
            {
                "n_rp": 26,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[2]/sec[10]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[10]/p[2]),1,189)",
                "containers_title": [
                    "Materials and methods",
                    "Immunoprecipitation and western blotting"
                ]
            }
        ],
        [
            {
                "n_rp": 27,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p[1]),1,74)",
                "containers_title": [
                    "Results",
                    "Effects of HOCl-RSA and SS-31 administration on oxidative parameters"
                ]
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p[3]),745,53)",
                "containers_title": [
                    "Results",
                    "Effects of HOCl-RSA and SS-31 administration on oxidative parameters"
                ]
            }
        ],
        [
            {
                "n_rp": 29,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),925,84)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 30,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),1118,213)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "Our data indicated that SS-31 prevented podocyte loss and apoptosis along with an increase of urinary protein and aggravation of renal pathological injury (as evidenced by hypertrophy and basement membrane thickening or segmental sclerosis in glomeruli, as well as focal detachment, necrosis and granular and vacuolar degeneration in tubular epithelial cells), all of which were enhanced by HOCl-RSA administration in DM rats. SS-31 had no effect on blood glucose, indicating that the protection of SS-31 was independent of hypoglycaemic effects. The benefits of SS-31 were further confirmed by in vitro experimental data that showed that SS-31 dose-dependently prevented HOCl-MSA-induced podocyte apoptosis. Podocyte injury manifested as the fusion of the foot process, hypertrophy, detachment, loss or death, led to glomerular sclerosis and was an important cellular basis for the initiation and early development of DKD. The reduction of the podocyte number indicated the progression of glomerulopathy28. Therefore, an effective therapy for podocyte injury might retard the progression of DKD at an early stage. Similar to our results, olmesartan29, valsartan, and mycophenolate mofetil30,31 all prevented microalbuminuria and progression of DKD through inhibition of loss or apoptosis of podocytes in animals with DM. Astragaloside ameliorated glomerular sclerosis and renal inflammation by inhibiting podocyte apoptosis in a DM mouse model32, and metformin regulated human podocytes apoptosis under high glucose conditions in vitro33.",
                "pl_xpath": "/article/body/sec[4]/p[2]"
            },
            {
                "n_rp": 31,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),1118,213)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "Our data indicated that SS-31 prevented podocyte loss and apoptosis along with an increase of urinary protein and aggravation of renal pathological injury (as evidenced by hypertrophy and basement membrane thickening or segmental sclerosis in glomeruli, as well as focal detachment, necrosis and granular and vacuolar degeneration in tubular epithelial cells), all of which were enhanced by HOCl-RSA administration in DM rats. SS-31 had no effect on blood glucose, indicating that the protection of SS-31 was independent of hypoglycaemic effects. The benefits of SS-31 were further confirmed by in vitro experimental data that showed that SS-31 dose-dependently prevented HOCl-MSA-induced podocyte apoptosis. Podocyte injury manifested as the fusion of the foot process, hypertrophy, detachment, loss or death, led to glomerular sclerosis and was an important cellular basis for the initiation and early development of DKD. The reduction of the podocyte number indicated the progression of glomerulopathy28. Therefore, an effective therapy for podocyte injury might retard the progression of DKD at an early stage. Similar to our results, olmesartan29, valsartan, and mycophenolate mofetil30,31 all prevented microalbuminuria and progression of DKD through inhibition of loss or apoptosis of podocytes in animals with DM. Astragaloside ameliorated glomerular sclerosis and renal inflammation by inhibiting podocyte apoptosis in a DM mouse model32, and metformin regulated human podocytes apoptosis under high glucose conditions in vitro33.",
                "pl_xpath": "/article/body/sec[4]/p[2]"
            },
            {
                "n_rp": 32,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),1118,213)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "Our data indicated that SS-31 prevented podocyte loss and apoptosis along with an increase of urinary protein and aggravation of renal pathological injury (as evidenced by hypertrophy and basement membrane thickening or segmental sclerosis in glomeruli, as well as focal detachment, necrosis and granular and vacuolar degeneration in tubular epithelial cells), all of which were enhanced by HOCl-RSA administration in DM rats. SS-31 had no effect on blood glucose, indicating that the protection of SS-31 was independent of hypoglycaemic effects. The benefits of SS-31 were further confirmed by in vitro experimental data that showed that SS-31 dose-dependently prevented HOCl-MSA-induced podocyte apoptosis. Podocyte injury manifested as the fusion of the foot process, hypertrophy, detachment, loss or death, led to glomerular sclerosis and was an important cellular basis for the initiation and early development of DKD. The reduction of the podocyte number indicated the progression of glomerulopathy28. Therefore, an effective therapy for podocyte injury might retard the progression of DKD at an early stage. Similar to our results, olmesartan29, valsartan, and mycophenolate mofetil30,31 all prevented microalbuminuria and progression of DKD through inhibition of loss or apoptosis of podocytes in animals with DM. Astragaloside ameliorated glomerular sclerosis and renal inflammation by inhibiting podocyte apoptosis in a DM mouse model32, and metformin regulated human podocytes apoptosis under high glucose conditions in vitro33.",
                "pl_xpath": "/article/body/sec[4]/p[2]"
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),1333,221)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "Our data indicated that SS-31 prevented podocyte loss and apoptosis along with an increase of urinary protein and aggravation of renal pathological injury (as evidenced by hypertrophy and basement membrane thickening or segmental sclerosis in glomeruli, as well as focal detachment, necrosis and granular and vacuolar degeneration in tubular epithelial cells), all of which were enhanced by HOCl-RSA administration in DM rats. SS-31 had no effect on blood glucose, indicating that the protection of SS-31 was independent of hypoglycaemic effects. The benefits of SS-31 were further confirmed by in vitro experimental data that showed that SS-31 dose-dependently prevented HOCl-MSA-induced podocyte apoptosis. Podocyte injury manifested as the fusion of the foot process, hypertrophy, detachment, loss or death, led to glomerular sclerosis and was an important cellular basis for the initiation and early development of DKD. The reduction of the podocyte number indicated the progression of glomerulopathy28. Therefore, an effective therapy for podocyte injury might retard the progression of DKD at an early stage. Similar to our results, olmesartan29, valsartan, and mycophenolate mofetil30,31 all prevented microalbuminuria and progression of DKD through inhibition of loss or apoptosis of podocytes in animals with DM. Astragaloside ameliorated glomerular sclerosis and renal inflammation by inhibiting podocyte apoptosis in a DM mouse model32, and metformin regulated human podocytes apoptosis under high glucose conditions in vitro33.",
                "pl_xpath": "/article/body/sec[4]/p[2]"
            },
            {
                "n_rp": 34,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[4]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[2]),1333,221)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_string": "Our data indicated that SS-31 prevented podocyte loss and apoptosis along with an increase of urinary protein and aggravation of renal pathological injury (as evidenced by hypertrophy and basement membrane thickening or segmental sclerosis in glomeruli, as well as focal detachment, necrosis and granular and vacuolar degeneration in tubular epithelial cells), all of which were enhanced by HOCl-RSA administration in DM rats. SS-31 had no effect on blood glucose, indicating that the protection of SS-31 was independent of hypoglycaemic effects. The benefits of SS-31 were further confirmed by in vitro experimental data that showed that SS-31 dose-dependently prevented HOCl-MSA-induced podocyte apoptosis. Podocyte injury manifested as the fusion of the foot process, hypertrophy, detachment, loss or death, led to glomerular sclerosis and was an important cellular basis for the initiation and early development of DKD. The reduction of the podocyte number indicated the progression of glomerulopathy28. Therefore, an effective therapy for podocyte injury might retard the progression of DKD at an early stage. Similar to our results, olmesartan29, valsartan, and mycophenolate mofetil30,31 all prevented microalbuminuria and progression of DKD through inhibition of loss or apoptosis of podocytes in animals with DM. Astragaloside ameliorated glomerular sclerosis and renal inflammation by inhibiting podocyte apoptosis in a DM mouse model32, and metformin regulated human podocytes apoptosis under high glucose conditions in vitro33.",
                "pl_xpath": "/article/body/sec[4]/p[2]"
            }
        ],
        [
            {
                "n_rp": 35,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),128,313)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 36,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),633,280)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_xpath": "substring(string(/article/body/sec[4]/p[3]),724,11)",
                "pl_string": "y\n34\n\n,\n\n35"
            },
            {
                "n_rp": 37,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),633,280)",
                "containers_title": [
                    "Discussion"
                ],
                "pl_xpath": "substring(string(/article/body/sec[4]/p[3]),724,11)",
                "pl_string": "y\n34\n\n,\n\n35"
            }
        ],
        [
            {
                "n_rp": 38,
                "xref_id": "CIT0036",
                "rp_string": "36",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),915,171)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 39,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),1088,101)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 40,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),1191,79)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 41,
                "xref_id": "CIT0038",
                "rp_string": "38",
                "rp_xpath": "/article/body/sec[4]/p[3]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[3]),1272,67)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 42,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),54,107)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 43,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),163,204)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 44,
                "xref_id": "CIT0041",
                "rp_string": "41",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),369,63)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0043",
                "rp_string": "43",
                "rp_xpath": "/article/body/sec[4]/p[4]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[4]/p[4]),651,223)",
                "containers_title": [
                    "Discussion"
                ]
            }
        ]
    ]
}